Home » Newsletters » BioWorld

BioWorld

Jan. 29, 1992

View Archived Issues

ANALYST PREDICTS FDA WILL APPROVE E5

Growth Factor Antibody Prevents Scars

COLLAGEN SALES CONTINUE TO LAG

BUSH PROMISES $76 BILLION FOR TECHNOLOGY

MATRIX IPO RAKES IN $52.5 MILLION

SECONDARY NETS NOVA $28.5 MILLION

TSI RAISES $25 MILLION IN OFFERING

FDA APPROVES ELAN'S NICOTINE PATCH

TRIPLEX TO CO-DEVELOP DRUGS WITH HOECHST